DE   EN   ES   FR   IT   PT


medicalmeds.eu Cardiology Atherosclerosis of coronary arteries

Atherosclerosis of coronary arteries



Description:


Atherosclerosis of coronary arteries is a defeat coronal, feeding heart, arteries at which their gleam is narrowed, and blood supply of heart decreases.
Defeat by atherosclerosis of coronary arteries — process chronic, developing for many years — happens defeat of coronary arteries (they grow coarse, in them the blood stream is broken) not in one, and in several zones. There can be various types of arteries in whom plaques and places of their education develop that is shown by unequal symptoms the First signal of defeat of coronary arteries are short-term pristupoobrazny pressing and/or thermalgias in retrosternal area (emergence of stenocardia) or ST interval shift on an ECG (bezbolevy ischemia of a myocardium — is worse as there is no signal to the patient). At an early stage of development of atherosclerosis of coronary arteries process can be clinically asymptomatic as at rest heart receives enough blood for ensuring requirements of his myocardium, but there is not enough at significant FN or contagious excitations.

Атеросклероз коронарных артерий - причина развития стенокардии

Atherosclerosis of coronary arteries - the reason of development of stenocardia


Symptoms of Atherosclerosis of coronary arteries:


Atherosclerosis of coronal arteries of heart not always proves at once. Often the disease asymptomatically injures many years heart and vessels and if it is not carried out timely diagnosis and treatment, leads to stenocardia, a myocardial infarction, disturbances of a cordial rhythm and heart failure.

In most cases, in the presence of symptoms of coronary heart disease, diagnosis of a disease does not cause difficulties. Such methods as an ECG, daily monitoring an ECG, an echocardiography, radionuclide researches, exercise tolerance tests (a veloergometriya and the tredmil-test) are for this purpose used.


Reasons of Atherosclerosis of coronary arteries:


Many external and internal factors are the reason of development of atherosclerosis of coronary vessels. More than 200 reasons which can lead to development of atherosclerosis are described. Permanent disturbances of proportions of contents in a blood plasma of various classes of lipids usually have heredo-familial character. Besides heredity can be defined by the resistant eating habits including the regular use of the food containing excess of the fats of animal origin rich with cholesterol.

The alimentary factor easily is implemented at insufficient development by a liver of the enzymes destroying cholesterol. And also arterial hypertension, obesity, insufficient physical activity and smoking.


Treatment of Atherosclerosis of coronary arteries:


Treatment: a diet with the reduced level of cholesterol: fats no more than 30%, from them animal origin – 7%. Physical exercises not less than 30 minutes 3 р / week, active lifestyle.

Medicinal therapy (reception of hypolipidemic means – statines) is appointed: after 6 months of dietary therapy for primary prevention. With at least one risk factor and the level of LNP cholesterol of 190 mg of %, existence of two and more risk factors and level of LNP cholesterol of 160 mg of %.

In the presence of complications (an ischemic heart disease, arrhythmias, a myocardial infarction in the anamnesis) - after 6-12 months of a dietotherapy and concentration of LNP cholesterol – more than 130 mg of %. Treatment duration – of several years or during all life.



Drugs, drugs, tablets for treatment of Atherosclerosis of coronary arteries:

  • Препарат Симвастатин.

    Simvastatin

    Hypolipidemic means.

    CJSC ZIO-Zdorovye Russia

    3

  • Препарат Овенкор.

    Ovenkor

    Hypolipidemic means.

    LLC Ozon Russia

  • Препарат Симвастатин.

    Simvastatin

    Hypolipidemic means - KOA-reductase GMG inhibitor.

    CJSC Verteks Russia

  • Препарат Симвастатин.

    Simvastatin

    Hypolipidemic means - KOA-reductase GMG inhibitor.

    CJSC Verteks Russia

  • Препарат Ловастатин.

    Lovastatin

    Hypolipidemic means - KOA-reductase GMG inhibitor.

    SOOO "Lekfarm" Republic of Belarus

  • Препарат Симвакор-Дарница.

    Simvakor-Darnitsa

    Hypolipidemic means – KOA-reductase GMG inhibitors.

    CJSC Pharmaceutical Firm Darnitsa Ukraine

  • Препарат Симвастатин-СЗ таб 10/20/40мг №30.

    Simvastatin-SZ таб 10/20/40mg No.

    Hypolipidemic means - KOA-reductase GMG inhibitor.

    CJSC Severnaya Zvezda Russia

  • Препарат Симвор.

    Simvor

    Hypolipidemic means - KOA-reductase GMG inhibitor.

    Ranbaxy Laboratories Ltd, Ind. Area (Ranbaksi Laboratoriz Ltd, Indus Erea) India

  • Препарат Холетар®.

    Холетар®

    Hypolipidemic means - KOA-reductase GMG inhibitor.

    Krka Slovenia

  • Препарат Тиоктовая кислота.

    Thioctic acid

    tgepatoprotektorny means.

    SC Balkan Pharmaceuticals SRL (Balkans Pharmasyyutikals) Republic of Moldova

  • Препарат Симвалип-ЛФ.

    Simvalip-LF

    Hypolipidemic drugs.

    SOOO "Lekfarm" Republic of Belarus

  • Препарат Тиоктовая кислота.

    Thioctic acid

    Hepatoprotective means.

    SC Balkan Pharmaceuticals SRL (Balkans Pharmasyyutikals) Republic of Moldova

  • Препарат Зовастикор, таблетки.

    Zovastikor, tablets

    Hypolipidemic drugs. Gipokholesterinemichesky and gipotriglitseridemichesky drugs. GMG-KOA-reduktazy inhibitors.

    JSC Borisovsky Plant of Medical Supplies Republic of Belarus

  • Препарат Симвастатин.

    Simvastatin

    Hypolipidemic means - KOA-reductase GMG inhibitor.

    CJSC ALSI Pharm Russia

  • Препарат Симвастатин-СЗ таб 10/20/40мг №30.

    Simvastatin-SZ таб 10/20/40mg No.

    Hypolipidemic means - KOA-reductase GMG inhibitor.

    CJSC Severnaya Zvezda Russia

  • Препарат Акталипид.

    Aktalipid

    Hypolipidemic means - KOA-reductase GMG inhibitor.

    Actavis Ltd. (Aktavis Ltd.) Switzerland

  • Препарат Акталипид.

    Aktalipid

    Hypolipidemic means - KOA-reductase GMG inhibitor.

    Actavis Ltd. (Aktavis Ltd.) Switzerland

  • Препарат Мевакор®.

    Мевакор®

    Gipokholesterinemichesky and gipotriglitseridemichesky means. Inhibitor of GMG-KOA-reduktazy (Statins).

    Merck Sharp & Dohme Corp. (Merck Sharp and Doum of the Building) USA

  • Препарат Симвастатин-СЗ таб 10/20/40мг №30.

    Simvastatin-SZ таб 10/20/40mg No.

    Hypolipidemic means – GMG-KOA-reduktazy inhibitor

    CJSC Severnaya Zvezda Russia

  • Препарат Симвакард®.

    Симвакард®

    Hypolipidemic means – GMG-KOA-reduktazy inhibitor

    Zentiva (Zentiva) Czech Republic


  • Сайт детского здоровья